Six companies reported actual earnings results this week alongside 11 guidance updates out of 91 total ASX announcements. Healthcare technology leader FPH delivered strong revenue growth of 14% to $2.31 billion with 24% profit growth, while infrastructure investor IFT reported an 11% uplift in operational EBITDAF. Sentiment was predominantly positive with several companies upgrading guidance.
Earnings Results
Fisher & Paykel Healthcare (FPH)
Fisher & Paykel Healthcare posted strong FY2026 results with revenue growing 14% to $2.31 billion and net profit after tax rising 24% to $468.5 million. The healthcare technology company's shares gained 12.9% over the week to $31.21, following reports that the earnings showed strong performance and resilient margins. The Hospital segment was the standout performer with 18% revenue growth to $1.51 billion, driven by 16% growth in consumables as changing clinical practices continued to drive demand despite subdued seasonal respiratory illness admissions. Gross margin expanded 80 basis points to 63.7%, reflecting continuous improvement initiatives that more than offset a 90 basis points headwind from US tariffs.
The company declared a final dividend of 52 cents per share and provided FY2027 guidance for revenue of $2.45-2.57 billion and net profit of $500-550 million, indicating continued momentum despite headwinds from geopolitical factors.
Infratil Limited (IFT)
New Zealand-listed infrastructure investor Infratil delivered an 11% uplift in proportionate operational EBITDAF to NZ$989 million in FY26, with shares rising 0.9% to $13.20 over the week. The result comes amid reports that the stock hit new all-time highs following the strong performance. Data centre business CDC was a key driver with EBITDAF up 19% to A$393 million, while renewable energy platform Longroad Energy surged 170% to US$121 million. CDC now operates over 1GW of contracted capacity and expects to exceed A$1 billion EBITDAF in FY28.
The company maintained strong growth outlook with FY27 guidance of NZ$1,300-1,400 million EBITDAF, representing approximately 21% growth on a like-for-like basis. Management also announced a final dividend of 20.9 cents per share.
Nufarm (NUF)
Agricultural chemicals company Nufarm reported HY26 revenue of $1.71 billion, down 5.3% year-on-year, but underlying net profit after tax grew 35.4% to $52.1 million. The company's shares surged 23.6% over the week to $2.99, following analyst commentary from Bell Potter recommending a buy rating. Despite lower Crop Protection volumes and FX headwinds, underlying gross profit margin expanded 370 basis points to 33.1%, reflecting structurally higher hybrid seed margins and improved product mix.
The board declared no interim dividend as it maintains capital discipline with leverage at 3.6x and net debt of $1.23 billion. Underlying EBITDA increased 18% to $242.7 million, demonstrating strong operational leverage from the company's focus on earnings quality over volume growth.
Webjet (WEB)
Web Travel Group delivered record FY26 results with revenue up 20% to $394.1 million and underlying EBITDA up 23% to $148.4 million. Shares gained 12.9% over the week to $2.62, though this follows earlier reports that the stock had crashed to record lows due to war impacts on travel. The Americas region was particularly strong with bookings up 41%, while Europe showed good recovery. Total bookings grew 18% to 9.9 million with total transaction value up 20% to $5.8 billion.
Net profit after tax was $85.9 million, up 8%, with earnings per share of 23.8 cents. The company maintained market-leading margins despite geopolitical headwinds in late February 2026.
Aroa Biosurgery (ARX)
AROA Biosurgery delivered strong FY26 results with total revenue of NZ$103.9 million, up 23% and exceeding guidance of NZ$92-100 million. Shares rose 9.6% over the week to 68.5 cents, with reports noting the company's profit turnaround. Normalised EBITDA surged to NZ$12.6 million from NZ$4.2 million in FY25, well above guidance of NZ$5-8 million. The Myriad products division was particularly strong with 54% growth.
Net profit after tax was NZ$6.88 million with earnings per share of 1.35 cents. The company ended with NZ$27.1 million cash and no debt. For FY27, management guided 13-23% constant currency revenue growth to NZ$115-125 million, though normalised EBITDA is expected to moderate to NZ$8-11 million due to deliberate investment in commercial expansion.
Trading Updates & Guidance
Charter Hall Group (CHC)
Charter Hall upgraded its FY26 operating earnings per security guidance by 3% to 103.0 cents per security, representing a 26.5% increase versus FY25. Shares gained 6.1% over the week to $20.51, with reports noting the guidance lift despite sector headwinds. The upgrade was driven by strong institutional capital momentum with $6.5 billion in year-to-date gross equity inflows and growth in funds under management to $74.7 billion.
ASX Limited (ASX)
ASX Limited provided FY27 financial guidance forecasting total expense growth of 18-21%, primarily driven by technology modernisation and ASIC Inquiry response costs. Shares fell 22.3% over the week to $46.21, following reports of surprise cost guidance. Capital expenditure guidance increased to $180-200 million for FY27 and $170-190 million for FY28. The company will also sell its 49% stake in Sympli to joint venture partner ATI Group for a nominal amount, recognising an after-tax loss of approximately $12 million.
Viva Leisure (VVA)
Viva Leisure upgraded FY26 statutory NPAT guidance to exceed $12 million, up 130% versus FY25, while underlying NPAT is expected to exceed $17 million. Shares rose 9.4% over the week to $1.575. The upgrade reflects margin expansion, strong TPLR division performance up 30% year-on-year, and improved network utilisation at 80%.
Other Notable Updates
Eagers Automotive announced record revenue of $13 billion, up 16.5%, while detailing strategic expansions including investments in Canadian and Australian dealership operations. Infragreen Group guided underlying EBITDA of $22.5-25 million for FY26, representing 21-35% growth, with FY27 guidance of $26-28 million.
Weekly Price Movers
Notable Shareholder Movements
Several significant institutional movements were recorded during the week. State Street Corporation became a substantial holder in Elsight Limited with a 5.44% stake, while UBS Group AG crossed the substantial holder threshold in Temple & Webster Group with 5.11%. Citigroup was active across multiple positions, becoming a substantial holder in Credit Corp Group (5.42%), 4Dmedical Limited (5.05%), and Droneshield Limited (5.00%). Meanwhile, there were multiple substantial holder movements in CAR Group involving MUFG and First Sentier Group, and Macquarie Group became a substantial holder in HLS with a 5.06% position.
With several major companies having reported this week, attention will turn to the broader reporting season in coming weeks as more ASX-listed companies release their full-year and half-year results. The mixed results this week, with strong performances from healthcare and infrastructure companies but guidance challenges for some sectors, suggest investors will be closely watching for signs of broader economic trends in upcoming releases.